Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD Anderson Cancer Center have uncovered a biomarker capable of accurately ...

The new study is more evidence that the official U.S. tally of confirmed human bird flu infections — 68 in the last year — is likely a significant undercount, said Dr. Gregory Gray, an infectious ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / University Diagnostic Medical Imaging, PCrecentlydisclosed that it suffered a data breach ...

“The findings highlight disparities in women’s health research and advocate for a more inclusive approach that considers ...

New serine biomarkers show promise for early Alzheimer's detection, linking tau assemblies to cognitive decline and offering ...

Medicare beneficiaries often pay monthly premiums, copays, annual deductibles and prescription drug costs. But what you may ...

Similarly, when medical device manufacturers require automated assembly systems for complex applications, they, too, turn to ...

Car manufacturers are known to make changes to their branding, and the supercar company McLaren is no different. Here's how its logo has evolved over the years.

The city of Dallas and a streetwear brand are duking it out over who can lay claim to the distinctive ‘D’ logo. Dallas is prepared to spend big to protect its logo. In fact, the Dallas City Council ...

Explore the fascinating stories behind 11 iconic vintage car logos. Learn how design, history, and identity shaped these timeless automotive symbols.

Barclays analyst Luke Sergott maintained a Hold rating on Quest Diagnostics (DGX – Research Report) today and set a price target of $168.00. The company’s shares closed yesterday at $159.97.

Physicians and patients to benefit from access to Quest's industry-leading test menu and broad health plan relationships in Ohio With the acquisition, Quest broadens access to its industry-leading ...